Syed Najmuddin, S. U. F. (2019). Efficacy of recombinant Newcastle disease virus, RAF-IL12 as a potential therapeutic cancer vaccine in CT26 and HT29 cancer cell line and in mouse model.
Chicago Style (17th ed.) CitationSyed Najmuddin, Syed Umar Faruq. Efficacy of Recombinant Newcastle Disease Virus, RAF-IL12 as a Potential Therapeutic Cancer Vaccine in CT26 and HT29 Cancer Cell Line and in Mouse Model. 2019.
MLA (8th ed.) CitationSyed Najmuddin, Syed Umar Faruq. Efficacy of Recombinant Newcastle Disease Virus, RAF-IL12 as a Potential Therapeutic Cancer Vaccine in CT26 and HT29 Cancer Cell Line and in Mouse Model. 2019.
Warning: These citations may not always be 100% accurate.